BUD vs GH
BUD (BUD) versus Guardant Health Inc (GH) — a side-by-side from cached financials, not a winner call.
BUD (BUD) common stock.
Guardant Health Inc (GH) is a diagnostics & research company listed on US.
BUD does not have a complete income-statement cache yet.
Latest reported GH revenue for 2024-12-31 was $739.0M. Net income was -$436.4M. Revenue was up 31.0% from 2023-12-31 to 2024-12-31. GH currently screens at market cap $6.32B.
BUD currently screens at market cap $0. GH currently screens at market cap $6.32B.
Not investment advice. Open the BUD and GH stock pages for the full models.
Not investment advice.